Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Novel Immunomodulatory and Anticoagulant Therapies for Recurrent Pregnancy Loss

NCT02990403 is registered in ClinicalTrials.gov with Shanghai First Maternity and Infant Hospital as lead sponsor.

NCT NCT02990403
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02990403 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Novel Immunomodulatory and Anticoagulant Therapies for Recurrent Pregnancy Loss
Lead sponsor
Shanghai First Maternity and Infant Hospital
Phase
Phase 4
Overall status
Unknown status
Start date
October 31, 2014
Completion date
December 22, 2018
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent pregnancy loss